Show simple item record

dc.contributor.authorLake, MA. University of Cambridge, Cambridge
dc.date.accessioned2020-03-20T18:06:59Z
dc.date.available2020-03-20T18:06:59Z
dc.date.issued2020-03-18
dc.identifier.urihttps://www.rcpjournals.org/content/clinmedicine/20/2/124en_US
dc.identifier.urihttps://hdl.handle.net/20.500.12663/494
dc.description.abstractIn December 2019, health authorities in Wuhan, China, identified a cluster of pneumonia cases of unknown aetiology linked to the city's South China Seafood Market. Subsequent investigations revealed a novel coronavirus, SARS-CoV-2, as the causative agent now at the heart of a major outbreak. The rising case numbers have been accompanied by unprecedented public health action, including the wholesale isolation of Wuhan. Alongside this has been a robust scientific response, including early publication of the pathogen genome, and rapid development of highly specific diagnostics. This article will review the new knowledge of SARS-CoV-2 COVID-19 acute respiratory disease, and summarise its clinical features.en_US
dc.language.isoEnglish
dc.titleWhat we know so far: COVID-19 current clinical knowledge and researchen_US
eihealth.countryEnglanden_US
eihealth.categoryClinical characterization and managementen_US
eihealth.typePublished Articleen_US
eihealth.maincategorySave Lives / Salvar Vidasen_US
dc.relation.ispartofjournalClinical Medicine Journal


Files in this item

FilesSizeFormatView

There are no files associated with this item.

This item appears in the following Collection(s)

Show simple item record